Submitted by Anonymous (not verified) on 4 February 2026 - 13:21
Human medicines European public assessment report (EPAR): Leqembi, lecanemab, Date of authorisation: 15/04/2025, Revision: 2, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Leqembi, lecanemab, Date of authorisation: 15/04/2025, Revision: 2, Status: Authorised